Evaluacija tvari - CoRAP

Evaluacija tvari - CoRAP

Evaluacija tvari - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
Suspected PMT/vPvM: Potentially Persistent, Mobile and Toxic/very Persistent and very Mobile.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 18 lipnja 2024. Database contains 402 unique substances/entries.
Filter the list
Initial grounds for concern:

The List does not contain any Substances.
 
205-739-4
149-44-0
2026
Netherlands
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
941-303-6
-
2026
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Not started
Details
215-609-9
1333-86-4
2026
France
Carcinogenic
Suspected Reprotoxic
Consumer use
Cumulative exposure
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
931-700-2
-
2026
France
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
1 - 4.5 moles ethoxylated
500-082-2
32492-61-8
2026
France
Suspected Mutagenic
Potential endocrine disruptor
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
947-768-1
-
2025
Netherlands
Suspected Mutagenic
Other hazard based concern
Exposure of workers
Wide dispersive use
Not started
Details
905-459-9
-
2025
France
Suspected Reprotoxic
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Not started
Details
701-246-8
-
2025
Spain
Suspected PBT/vPvB
Consumer use
Exposure of environment
Wide dispersive use
Not started
Details
701-463-8
-
2025
Spain
Suspected PBT/vPvB
Consumer use
Exposure of environment
Wide dispersive use
Not started
Details
The complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isononanal. It consists predominantly of C6 olefins and paraffins and C9 alcohols and aldehydes and boiling in the range of approximately 110°C to 202°C (230°F to 396°F).
273-110-1
68938-03-4
2025
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Not started
Details
200-467-2
60-29-7
2025
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
218-487-5
2162-74-5
2025
Italy
Suspected PBT/vPvB
Exposure of workers
Wide dispersive use
Not started
Details
202-860-4
100-52-7
2025
France
Suspected Mutagenic
Consumer use
Exposure of workers
Wide dispersive use
Not started
Details
247-118-0
25584-83-2
2025
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Not started
Details
CD 28-0132; IRGALUBE 232
421-820-9
192268-65-8
2025
Netherlands
Suspected PBT/vPvB
Not started
Details
D-8; DD-8
405-520-5
95235-30-6
2025
Belgium
Potential endocrine disruptor
Other exposure/risk based concern
Not started
Details
202-826-9
100-18-5
2025
France
Suspected Reprotoxic
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Exposure of workers
Not started
Details
202-773-1
99-62-7
2025
France
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of workers
Not started
Details
257-573-7
51981-21-6
2024
France
Suspected Carcinogenic
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
203-499-5
107-52-8
2024
Spain
Suspected PBT/vPvB
Consumer use
Exposure of environment
Wide dispersive use
Ongoing
Details
212-791-1
870-08-6
2024
Austria
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
233-215-5
10081-67-1
2024
Sweden
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
227-033-5
5613-46-7
2024
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
217-121-1
1745-89-7
2024
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
244-815-1
22174-70-5
2024
Ireland
Suspected Reprotoxic
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details

Export search results to: